ACHN
Achillion Pharmaceuticals, Inc.
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
147 hedge funds and large institutions have $852M invested in Achillion Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 55 increasing their positions, 44 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
-6
Holders Change %
-3.92%
% of All Funds
3.93%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
17
Increased
55
Reduced
44
Closed
20
Calls
$10M
Puts
$3.6M
Net Calls
+$6.4M
Net Calls Change
-$4.11M
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$10.8M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$5.69M |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$3.95M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.55M |
| 5 |
O
OrbiMed
New York
|
+$1.26M |
